GB0020691D0 - Pharmaceutical combination - Google Patents

Pharmaceutical combination

Info

Publication number
GB0020691D0
GB0020691D0 GBGB0020691.2A GB0020691A GB0020691D0 GB 0020691 D0 GB0020691 D0 GB 0020691D0 GB 0020691 A GB0020691 A GB 0020691A GB 0020691 D0 GB0020691 D0 GB 0020691D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical combination
pharmaceutical
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0020691.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32234234&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB0020691(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG, Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Priority to GBGB0020691.2A priority Critical patent/GB0020691D0/en
Publication of GB0020691D0 publication Critical patent/GB0020691D0/en
Priority to DE10108215A priority patent/DE10108215A1/de
Priority to EP06000777A priority patent/EP1671632A1/en
Priority to CN01814414A priority patent/CN1447691A/zh
Priority to IL15393701A priority patent/IL153937A0/xx
Priority to AU2001295465A priority patent/AU2001295465B2/en
Priority to BR0113321-7A priority patent/BR0113321A/pt
Priority to UY26893A priority patent/UY26893A1/es
Priority to EA200300224A priority patent/EA200300224A1/ru
Priority to CN 200710001488 priority patent/CN101002766A/zh
Priority to KR10-2003-7002476A priority patent/KR20030064383A/ko
Priority to HR20030124A priority patent/HRP20030124A2/hr
Priority to SK206-2003A priority patent/SK2062003A3/sk
Priority to EEP200300075A priority patent/EE200300075A/xx
Priority to CZ2003534A priority patent/CZ2003534A3/cs
Priority to CA002415788A priority patent/CA2415788A1/en
Priority to MXPA03001509A priority patent/MXPA03001509A/es
Priority to HU0303836A priority patent/HUP0303836A2/hu
Priority to YU12703A priority patent/YU12703A/sh
Priority to PL01366419A priority patent/PL366419A1/xx
Priority to SG200501008-7A priority patent/SG148838A1/en
Priority to PCT/EP2001/009428 priority patent/WO2002015891A2/en
Priority to EP01976082A priority patent/EP1313468A2/en
Priority to NZ546884A priority patent/NZ546884A/en
Priority to JP2002520812A priority patent/JP2004520268A/ja
Priority to TW090120386A priority patent/TWI281858B/zh
Priority to ARP010104001A priority patent/AR030468A1/es
Priority to JP2002093288A priority patent/JP2003238444A/ja
Priority to CA002372785A priority patent/CA2372785A1/en
Priority to ZA200300556A priority patent/ZA200300556B/en
Priority to US10/354,713 priority patent/US20030171415A1/en
Priority to BG107558A priority patent/BG107558A/bg
Priority to NO20030761A priority patent/NO20030761L/no
Priority to US11/375,836 priority patent/US20060154976A1/en
Priority to US12/035,166 priority patent/US20080146639A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
GBGB0020691.2A 2000-08-22 2000-08-22 Pharmaceutical combination Ceased GB0020691D0 (en)

Priority Applications (35)

Application Number Priority Date Filing Date Title
GBGB0020691.2A GB0020691D0 (en) 2000-08-22 2000-08-22 Pharmaceutical combination
DE10108215A DE10108215A1 (de) 2000-08-22 2001-02-20 Pharmazeutische Kombination von Antagonisten von Angiotensin II und Hemmern von Angiotensin II konvertierendem Enzym
NZ546884A NZ546884A (en) 2000-08-22 2001-08-16 Co-administration of an angiotensin II (ANG II) antagonist and an ACE inhibitor for treating congestive heart failure
JP2002520812A JP2004520268A (ja) 2000-08-22 2001-08-16 アンギオテンシンｉｉ拮抗剤とアンギオテンシンｉ変換酵素阻害剤とを含有する医薬組成物
CA002415788A CA2415788A1 (en) 2000-08-22 2001-08-16 Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
PL01366419A PL366419A1 (en) 2000-08-22 2001-08-16 Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
IL15393701A IL153937A0 (en) 2000-08-22 2001-08-16 Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
AU2001295465A AU2001295465B2 (en) 2000-08-22 2001-08-16 Pharmaceutical combination of angiotensin II antagonists and ace inhibitors
BR0113321-7A BR0113321A (pt) 2000-08-22 2001-08-16 Combinação farmacêutica de antagonistas de angiotensina ii e inibidores da enzima conversora de angiotensina i
UY26893A UY26893A1 (es) 2000-08-22 2001-08-16 Combinación farmacéutica de antagonistas de la angiotensina ii e inhibidores de la enzima de conversión de la angiotensina i
EA200300224A EA200300224A1 (ru) 2000-08-22 2001-08-16 Фармацевтическая комбинация антагонистов ангиотензина ii и ингибиторов асе
CN 200710001488 CN101002766A (zh) 2000-08-22 2001-08-16 血管紧张素ⅱ拮抗剂与血管紧张素ⅰ转换酶抑制剂的药物结合物
KR10-2003-7002476A KR20030064383A (ko) 2000-08-22 2001-08-16 안지오텐신 ⅱ 길항제 및 ａｃｅ 억제제의 약제학적 배합물
HR20030124A HRP20030124A2 (en) 2000-08-22 2001-08-16 Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
SK206-2003A SK2062003A3 (en) 2000-08-22 2001-08-16 Pharmaceutical combination of angiotensin II antagonists and ACE inhibitors
EEP200300075A EE200300075A (et) 2000-08-22 2001-08-16 Angiotensiin II antagonistide ja ACE inhibiitorite farmatseutiline kombinatsioon
CZ2003534A CZ2003534A3 (cs) 2000-08-22 2001-08-16 Farmaceutický prostředek
EP06000777A EP1671632A1 (en) 2000-08-22 2001-08-16 Pharmaceutical combination of angiotensin II antagonists and ACE inhibitors
MXPA03001509A MXPA03001509A (es) 2000-08-22 2001-08-16 Combinacion farmaceutica de antagonistas de la angiotensina ii e inhibidores de la enzima de conversion de la angiotensina i.
HU0303836A HUP0303836A2 (hu) 2000-08-22 2001-08-16 Angiotenzin antagonisták és ACE inhibitorok gyógyszerészeti kombinációja és ezeket tartalmazó gyógyszerkészítmények
YU12703A YU12703A (sh) 2000-08-22 2001-08-16 Farmaceutska kombinacija antagonista angiotenzina ii i inhibitora angiotenzin i konvertujućeg enzima
CN01814414A CN1447691A (zh) 2000-08-22 2001-08-16 血管紧张素ⅱ拮抗剂与血管紧张素ⅰ转换酶抑制剂的药物组合物
SG200501008-7A SG148838A1 (en) 2000-08-22 2001-08-16 Pharmaceutical combination of angiotensin ii antagonists and ace inhibitors
PCT/EP2001/009428 WO2002015891A2 (en) 2000-08-22 2001-08-16 Pharmaceutical combination of angiotensin ii antagonists and ace inhibitors
EP01976082A EP1313468A2 (en) 2000-08-22 2001-08-16 Pharmaceutical combination of angiotensin ii antagonists and ace inhibitors
TW090120386A TWI281858B (en) 2000-08-22 2001-08-20 Pharmaceutical combination of angiotensin II antagonists and angiotensin I converting enzyme inhibitors
ARP010104001A AR030468A1 (es) 2000-08-22 2001-08-22 Combinacion farmaceutica de antagonistas de la angiotensina ii e inhibidores de la enzima de conversion de la angiotensina i
JP2002093288A JP2003238444A (ja) 2000-08-22 2002-02-21 アンギオテンシンｉｉ拮抗剤及びアンギオテンシンｉ変換酵素阻害剤の医薬組成物
CA002372785A CA2372785A1 (en) 2000-08-22 2002-02-21 Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
ZA200300556A ZA200300556B (en) 2000-08-22 2003-01-21 Pharmaceutical combination of angiotensin II antagonists and ace inhibitors.
US10/354,713 US20030171415A1 (en) 2000-08-22 2003-01-30 Pharmaceutical combination of angiotensin II antagonists and angiotensin I converting enzyme inhibitors
BG107558A BG107558A (bg) 2000-08-22 2003-02-14 Фармацевтична комбинация от ангиотензин ii антагонисти ii ангиотензин i конвертиращи ензимни инхибитори
NO20030761A NO20030761L (no) 2000-08-22 2003-02-18 Farmasöytisk kombinasjon av angiotensin II antagonister og angiotensin I konverterende enzyminhibitorer
US11/375,836 US20060154976A1 (en) 2000-08-22 2006-03-15 Pharmaceutical combination of angiotensin II antagonists and angiotensin I converting enzyme inhibitors
US12/035,166 US20080146639A1 (en) 2000-08-22 2008-02-21 Pharmaceutical Combination of Angiotensin II Antagonists and Angiotensin I Converting Enzyme Inhibitors

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB0020691.2A GB0020691D0 (en) 2000-08-22 2000-08-22 Pharmaceutical combination
DE10108215A DE10108215A1 (de) 2000-08-22 2001-02-20 Pharmazeutische Kombination von Antagonisten von Angiotensin II und Hemmern von Angiotensin II konvertierendem Enzym
CA002372785A CA2372785A1 (en) 2000-08-22 2002-02-21 Pharmaceutical combination of angiotensin ii antagonists and angiotensin i converting enzyme inhibitors
JP2002093288A JP2003238444A (ja) 2000-08-22 2002-02-21 アンギオテンシンｉｉ拮抗剤及びアンギオテンシンｉ変換酵素阻害剤の医薬組成物

Publications (1)

Publication Number Publication Date
GB0020691D0 true GB0020691D0 (en) 2000-10-11

Family

ID=32234234

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0020691.2A Ceased GB0020691D0 (en) 2000-08-22 2000-08-22 Pharmaceutical combination

Country Status (15)

Country Link
US (1) US20030171415A1 (https=)
EP (1) EP1313468A2 (https=)
JP (1) JP2003238444A (https=)
CN (1) CN1447691A (https=)
AU (1) AU2001295465B2 (https=)
BG (1) BG107558A (https=)
BR (1) BR0113321A (https=)
CA (2) CA2415788A1 (https=)
CZ (1) CZ2003534A3 (https=)
DE (1) DE10108215A1 (https=)
GB (1) GB0020691D0 (https=)
IL (1) IL153937A0 (https=)
NO (1) NO20030761L (https=)
SK (1) SK2062003A3 (https=)
WO (1) WO2002015891A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
DK1216038T3 (da) * 1999-08-30 2005-12-27 Sanofi Aventis Deutschland Anvendelse af inhibitorer af reninangiotensinsystemet ved forebyggelsen af cardiovaskulære hændelser
US20040157911A1 (en) * 1999-08-31 2004-08-12 Spiridon Spireas Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof
US20040248968A1 (en) * 2002-02-20 2004-12-09 Boehringer Ingelheim International Gmbh Pharmaceutical combination of angiotensin II antagonists and angiotensin I converting enzyme inhibitors
DE10301371A1 (de) * 2003-01-16 2004-08-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Kombination zur Prophylaxe oder Therapie von kardiovaskulären, kardiopulmonalen, pulmonalen oder renalen Krankheiten
US9029363B2 (en) * 2003-04-30 2015-05-12 Boehringer Ingelheim International Gmbh Telmisartan sodium salt pharmaceutical formulation
US20050004194A1 (en) * 2003-05-15 2005-01-06 Graves Kurt Chum Use of organic compounds
US20040265238A1 (en) * 2003-06-27 2004-12-30 Imtiaz Chaudry Inhalable formulations for treating pulmonary hypertension and methods of using same
SE0302331D0 (sv) * 2003-08-29 2003-08-29 Astrazeneca Ab New use II
DE102004008804A1 (de) * 2004-02-20 2005-09-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Mehrschichttablette
WO2005097109A1 (en) * 2004-04-01 2005-10-20 Daniel Batlle Methods for achieving a protective ace2 expression level
DE602005025755D1 (de) 2004-06-04 2011-02-17 Teva Pharma Irbesartan enthaltende pharmazeutische zusammensetzung
EP1723962A1 (en) * 2005-05-19 2006-11-22 IMBA-Institut für Molekulare Biotechnologie GmbH Use of inhibitors of the renin-angiotensin system for the treatment of lung injuries
US8080534B2 (en) * 2005-10-14 2011-12-20 Phigenix, Inc Targeting PAX2 for the treatment of breast cancer
WO2009087116A1 (en) * 2008-01-11 2009-07-16 Novartis Ag Use of spp100 for the treatment of acute mi
EP2684564A1 (en) 2008-04-17 2014-01-15 Sanofi Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or in the prevention of atrial fibrillation
EP2116239A1 (en) * 2008-04-29 2009-11-11 Sanofi-Aventis Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment
CN101869710A (zh) * 2009-04-24 2010-10-27 北京奥萨医药研究中心有限公司 降压药物组合物
US8602215B2 (en) 2010-06-30 2013-12-10 Sanofi Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
US20140170158A1 (en) * 2012-12-17 2014-06-19 The Johns Hopkins University Compositions and methods for treating or preventing lung diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821232A (en) * 1990-05-11 1998-10-13 Pfizer Inc. Synergistic therapeutic compositions and methods
EP0629408A1 (en) * 1993-06-16 1994-12-21 LABORATOIRES MERCK, SHARP & DOHME-CHIBRET Combination of angiotensin converting enzyme inhibitors and AII antagonists
CZ313897A3 (cs) * 1995-04-07 1998-01-14 Novartis Ag Farmaceutické kompozice obsahující benazepril nebo benazeprilát a valsartan
JPH11508894A (ja) * 1995-06-30 1999-08-03 メルク エンド カンパニー インコーポレーテッド Ａｃｅ阻害剤とａｉｉ拮抗薬を用いる腎疾患の治療方法
JP2000513356A (ja) * 1996-06-24 2000-10-10 メルク エンド カンパニー インコーポレーテッド エナラプリルとロサルタンの組成物
US6465502B1 (en) * 1998-12-23 2002-10-15 Novartis Ag Additional therapeutic use
DK1216038T3 (da) * 1999-08-30 2005-12-27 Sanofi Aventis Deutschland Anvendelse af inhibitorer af reninangiotensinsystemet ved forebyggelsen af cardiovaskulære hændelser

Also Published As

Publication number Publication date
IL153937A0 (en) 2003-07-31
SK2062003A3 (en) 2003-08-05
WO2002015891A2 (en) 2002-02-28
CN1447691A (zh) 2003-10-08
AU9546501A (en) 2002-03-04
DE10108215A1 (de) 2002-08-22
CA2415788A1 (en) 2002-02-28
EP1313468A2 (en) 2003-05-28
NO20030761D0 (no) 2003-02-18
CZ2003534A3 (cs) 2003-06-18
BR0113321A (pt) 2003-07-15
WO2002015891A3 (en) 2002-06-13
BG107558A (bg) 2004-01-30
NO20030761L (no) 2003-02-18
CA2372785A1 (en) 2003-08-21
AU2001295465B2 (en) 2007-12-13
JP2003238444A (ja) 2003-08-27
US20030171415A1 (en) 2003-09-11

Similar Documents

Publication Publication Date Title
GB0006133D0 (en) Novel pharmaceutical
GB0025473D0 (en) Pharmaceutical combinations
GB0020691D0 (en) Pharmaceutical combination
GB0031084D0 (en) Pharmaceutical compounds
GB0012291D0 (en) Pharmaceutical combination
GB0019228D0 (en) Novel pharmaceutical
GB0021865D0 (en) Novel pharmaceutical
GB0019272D0 (en) Pharmaceutical compounds
GB0014006D0 (en) Novel pharmaceutical
GB0024318D0 (en) Pharmaceutical compounds
GB0019226D0 (en) Novel pharmaceutical
GB0019224D0 (en) Novel pharmaceutical
GB0012293D0 (en) Pharmaceutical combination
GB0021487D0 (en) Pharmaceutical
GB0014005D0 (en) Novel pharmaceutical
GB0023971D0 (en) Novel pharmaceutical
GB0005366D0 (en) Pharmaceutical compounds
GB0021785D0 (en) Novel Pharmaceutical
GB0019223D0 (en) Novel pharmaceutical
GB0023970D0 (en) Novel pharmaceutical
GB0017666D0 (en) Pharmaceutical combination
GB0016426D0 (en) Pharmaceutical combination
GB0016427D0 (en) Pharmaceutical combination
GB0020767D0 (en) Pharmaceutical combination
GB0016429D0 (en) Pharmaceutical combination

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)